Recipharm’s Board of Directors decides to withdraw dividend proposal
The outbreak of Covid-19 and the extraordinary measures and recommendations that authorities and governments have taken to reduce the spread of the Coronavirus have significantly affected operating conditions on the markets where Recipharm operates. Recipharm AB’s Board of Directors has therefore decided to withdraw the previously communicated dividend proposal of SEK 1.60 per share and will propose to the Annual General Meeting on May 12, 2020 that no dividend is paid. The decision does not constitute a change in Recipharm’s long-term dividend policy or future ambitions for dividend.
